> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Final Guide on Biological Deviation Reporting
- URL: https://www.fdaweb.com/final-guide-on-biological-deviation-reporting/
- Published: 2020-03-13T12:00:00.000Z
- Updated: 2026-09-14T16:07:09.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5146320

*Federal Register* notice: FDA has made available a final guidance entitled “Biological Product Deviation Reporting for Blood and Plasma Establishments.” The document provides blood and plasma establishments with revised recommendations related to biological product deviation reporting. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2020-03-13/pdf/2020-05103.pdf?ref=fdaweb.com).